NewLimit

Description

Develops medicines using AI-designed payloads and genomics testing to restore youthful function in old cells, targeting age-related cellular decline and human healthspan.

Related

• CalicoStudies aging and healthspan biology, combining research, computational biology, machine learning, and drug development to turn biological…
• Retro BiosciencesDevelops therapeutics targeting cellular mechanisms of aging to prevent or reverse age-related diseases and increase healthy lifespan…
• Sphere SemiBuilds AI-designed analog chips, starting with RF components and mixed-signal blocks, delivering validated custom chips and reusable IP for…
• Altos LabsDevelops medicines based on cell rejuvenation, using computation, machine learning, and internal and external biological data to study cell…
• Science CorporationDevelops medical and brain-computer interface technologies to help restore vision, cognition, and mobility for patients with debilitating…
• Sangamo Therapeutics ($SGMO)Develops genomic medicines using zinc finger technology for patients with severe diseases where current treatments may offer mainly symptom…
• HAYA TherapeuticsBuilds RNA-guided therapies that reprogram disease-driving cell states; used to reverse cell states and restore health in therapeutic…
• Poseida Therapeutics (Roche)Develops cell therapy candidates and related platform technologies, with legacy programs in a biotechnology pipeline for medicines…
• Life BiosciencesDevelops epigenetic restoration therapies intended to rejuvenate cells and treat age-related diseases, with an initial clinical trial…
• bit.bioBuilds deterministically programmed human iPSC-derived cells and related services for research and drug discovery customers seeking…
• Relay Therapeutics ($RLAY)Develops small molecule medicines using computational and experimental protein-motion analysis, targeting previously hard-to-drug precision…
• Gilgamesh PharmaceuticalsGilgamesh Pharma develops novel small molecules for psychiatric diseases, using medicinal chemistry and an AI-powered translational…